Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies
Pharmaceutics · 03.04.2023 · 15 (4) · 1130
DOI: 10.3390/pharmaceutics15041130 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 03.04.2023. Verfasst von Saeed Anwar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canada. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 372 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Muscular Dystrophy Canada, Friends of Garrett Cumming Re-search Fund, HM Toupin Neurological Science Research Fund.
Abstract (Originalsprache)
Oligonucleotide-based therapies are a promising approach for treating a wide range of hard-to-treat diseases, particularly genetic and rare diseases. These therapies involve the use of short synthetic sequences of DNA or RNA that can modulate gene expression or inhibit proteins through various mechanisms. Despite the potential of these therapies, a significant barrier to their widespread use is the difficulty in ensuring their uptake by target cells/tissues. Strategies to overcome this challenge include cell-penetrating peptide conjugation, chemical modification, nanoparticle formulation, and the use of endogenous vesicles, spherical nucleic acids, and smart material-based delivery vehicles. This article provides an overview of these strategies and their potential for the efficient delivery of oligonucleotide drugs, as well as the safety and toxicity considerations, regulatory requirements, and challenges in translating these therapies from the laboratory to the clinic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.
ORCID-Profile: Saeed Anwar, Toshifumi Yokota
Förderung
- Muscular Dystrophy Canada
- Friends of Garrett Cumming Re-search Fund
- HM Toupin Neurological Science Research Fund
- Canadian Institutes of Health Research
- Jesse’s Journey
- scholarships from the Maternal and Child Health (MatCH) Program
- Alberta Innovates Graduate Student Scholarship (AIGSS)
- Women and Children’s Health Research Institute (WCHRI)
Zitieren
APA
Anwar, S., Mir, F., & Yokota, T. (2023). Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies. Pharmaceutics, 15(4), 1130. https://doi.org/10.3390/pharmaceutics15041130
Vancouver
Anwar S, Mir F, Yokota T. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies. Pharmaceutics. 2023;15(4):1130. doi:10.3390/pharmaceutics15041130
BibTeX
@article{Anwar2023,
author = {Anwar, Saeed and Mir, Farin and Yokota, Toshifumi},
title = {Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {4},
pages = {1130},
doi = {10.3390/pharmaceutics15041130}
}
EUVIMED